Phase I/II trial of pomalidomide and dexamethasone in AL amyloidosis. (A) Treatment schema. (B) Outcome analysis: each bar represents an individual patient. The abscissa represents the time on study. (C) Overall survival from enrollment by Kaplan-Meier analysis. (D) Event-free survival by Kaplan-Meier analysis.